This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Cleveland-Cliffs (CLF) Up 23% in 3 Months: What's Driving It?
by Zacks Equity Research
Better-than-expected Q2 performance, upbeat outlook, strong demand and debt-reduction actions are contributing to the rally in Cleveland-Cliffs' (CLF) shares.
LyondellBasell (LYB) Up 29% in a Year: What's Driving It?
by Anindya Barman
Forecast-topping earnings performance, upbeat outlook and strong prospects stemming from the acquisition of A. Schulman have contributed to the rally in LyondellBasell's (LYB) shares.
Univar, Kerry Ingredients & Flavours Reach Taste Agreement
by Zacks Equity Research
Kerry's brand recognition will enable Univar (UNVR) to enhance its taste solution offerings.
Celanese (CE) Up 15% in 6 Months: What's Driving the Stock?
by Zacks Equity Research
Better-than-expected Q2 results and upbeat outlook drives Celanese's (CE) shares.
Is Huntsman (HUN) a High-Growth Dividend Stock?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Huntsman (HUN) have what it takes? Let's find out.
Top Ranked Value Stocks to Buy for August 27th
by Zacks Equity Research
Here are three stocks with buy rank and strong value characteristics for investors to consider today, August 27th:
Air Products (APD) Buys Rotoflow Turboexpander Business
by Zacks Equity Research
Air Products' (APD) latest buyout extends existing capabilities into growing petrochemical, energy and hydrocarbon segments.
Is Huntsman (HUN) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Eastman Chemical (EMN) Raises Prices of Plasticizers
by Zacks Equity Research
Eastman Chemical (EMN) increases Plasticizers prices due to elevated costs of raw materials.
Looking for Value? Why It Might Be Time to Try Huntsman (HUN)
by Zacks Equity Research
Huntsman (HUN) seems to be a good value pick, as it has decent revenue metrics to back up its earnings, and is seeing solid earnings estimate revisions as well.
CF Industries Up 19% in 3 Months: What's Driving the Stock?
by Anindya Barman
Better-than-expected Q2 results and upbeat nitrogen demand and pricing outlook have contributed to the rally in CF Industries' (CF) shares.
Huntsman (HUN) Opens New Manufacturing Facility in Vietnam
by Zacks Equity Research
The new site will house Huntsman's (HUN) polyurethanes and advanced materials businesses.
Eastman Chemical (EMN) Raises Prices of Acids and Alcohols
by Zacks Equity Research
Eastman Chemical (EMN) hikes acid and alcohol product prices due to higher market demand and elevated operating costs of raw materials.
LyondellBasell Initiates Construction of $2.4B PO/TBA Plant
by Zacks Equity Research
LyondellBasell (LYB) is building the plant to cater to the rising global demand for urethanes.
Mosaic (MOS) Stock Up 46% in a Year: What's Driving It?
by Anindya Barman
Strong earnings outlook, healthy demand and pricing trends for nutrients and upbeat prospects from the Vale Fertilizantes acquisition are driving Mosaic's (MOS) shares.
Methanex (MEOH) Up 26% in 6 Months: What's Behind the Rally?
by Anindya Barman
Strong demand and pricing fundamentals for methanol have contributed to the run up in Methanex's (MEOH) shares.
Harmony Gold's (HMY) Profits Drop, Sales Rise Y/Y in FY18
by Zacks Equity Research
Harmony Gold's (HMY) revenues improve 12% in FY18 owing to higher gold sales. It expects to produce 1.45 million oz of gold in fiscal 2019.
LyondellBasell (LYB) Wraps Up A. Schulman Acquisition
by Zacks Equity Research
The buyout doubles the size of LyondellBasell's (LYB) existing compounding business
Ingevity (NGVT) Up 26% in 3 Months: What's Behind the Rally?
by Anindya Barman
Forecast-topping Q2 results and upbeat outlook have contributed to the run-up in Ingevity's (NGVT) shares.
Cabot (CBT) Up 11% in 3 Months: What's Driving the Stock?
by Anindya Barman
Strong Q3 earnings and upbeat outlook for Reinforcement Materials and Performance Chemicals segments have contributed to the gain in Cabot's (CBT) shares.
Praxair (PX) & Linde Merger Obtains EU Antitrust Approval
by Zacks Equity Research
Praxair (PX) and Linde merger receives EU antitrust regulators' approval, taking a step forward for creation of a leading industrial gas company.
Air Products (APD) Clinches Jiutai Syngas Supply Contract
by Zacks Equity Research
Air Products (APD) to invest $650 million in the project, which is expected start in the fourth quarter of fiscal 2021.
5 Reasons to Add Cleveland-Cliffs Stock to Your Portfolio Now
by Zacks Equity Research
Strong fundamentals and upbeat prospects make Cleveland-Cliffs (CLF) an attractive investment choice.
5 Reasons That Make Celanese (CE) Stock a Solid Choice Now
by Anindya Barman
Strong growth prospects and upbeat outlook make Celanese (CE) an attractive investment option.
Here's Why You Should Hold on to Praxair (PX) Stock for Now
by Zacks Equity Research
Praxair (PX) to gain from growing energy and industrial end markets, strong backlog and new order wins despite concerns in Brazilian economy and a strong U.S. dollar.